Stonepine Capital Management fully exited its position in ANI Pharmaceuticals, selling 38,597 shares worth $2.52 million in Q3. Despite ANI's strong fundamentals—with Q3 revenue surging 54% YoY to $227.8 million and stock up 49% over the past year—the fund's exit appears to be a portfolio rebalancing move toward earlier-stage biotech rather than a loss of confidence. ANI's future returns will depend on sustained rare disease growth and margin discipline rather than multiple expansion.

AEON Biopharma announced the grant of 392,158 restricted stock units to newly hired non-executive employees on December 11, 2025, under its 2025 Inducement Incentive Plan. The RSUs vest over four years with 25% vesting annually. The company continues development of ABP-450, a BOTOX biosimilar targeting the $3 billion U.S. therapeutic neurotoxin market.

The article discusses the debut of Chinese boba tea chain Mixue on the Hong Kong stock exchange, the departure of Kroger's CEO due to personal conduct issues, and Domino's introduction of stuffed crust pizza. It also covers the booming med spa industry and the performance of Evolus, a competitor to Botox.

In our monthly Rare Stock Picks series, we're highlighting May 2024 investment picks. Click here for the list of May 2024 Buy recommendations.

The addition of Evolysse fillers to the company's portfolio complements Evolus' (EOLS) flagship neurotoxin Jeuveau.

Evolus (EOLS) delivered earnings and revenue surprises of -85.71% and 0.95%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Notable companies to have witnessed solid earnings acceleration as of now are Sana Biotechnology (SANA), LifeMD (LFMD), Evolus (EOLS) and Expro Group Holdings (XPRO).

Green Thumb Industries Inc. (GTBIF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Invest in stocks such as Protagonist Therapeutics (PTGX), Evolus (EOLS), Western Digital (WDC), and Phunware (PHUN) as of now for superb earnings acceleration.

The consensus price target hints at a 63.2% upside potential for Evolus, Inc. (EOLS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

TG Therapeutics (TGTX) delivered earnings and revenue surprises of 25% and 9.72%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped 65.5% to $1.47 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 133.8% to $1.2250 after the company requested the withdrawal of a recently filed registration statement. Also, the company announced preclinical data of its lead program PALI-2108 at the 2024 Crohn's & Colitis Congress. OneMedNet Corporation (NASDAQ: ONMD) surged 95% to $1.0401. OneMedNet announced participation as an exhibitor at the 15ᵗʰ Annual SCOPE Summit. Revelation Biosciences, Inc. (NASDAQ: REVB) shares climbed 65.8% to $16.37. Rail Vision Ltd. (NASDAQ: RVSN) gained 60% to $15.12. Connexa Sports Technologies Inc. (NASDAQ: CNXA) jumped 43% to $0.2200. Enviva Inc. (NYSE: EVA) surged 35.3% to $0.7830. Cardlytics, Inc. (NASDAQ: CDLX) surged 28% to $7.40 after the company announced it entered into a settlement agreement with SRS and updated preliminary Q4 2023 results. Lucid Group, Inc. (NASDAQ: LCID) gained 23% to $3.2703. Nyxoah S.A. (NASDAQ: NYXH) rose 22.5% to $11.53. Spectral AI, Inc. (NASDAQ: MDAI) climbed 20.2% to $3.2580 after gaining more than 35% on Friday. BTIG analyst Ryan Zimmerman recently initiated coverage on Spectral AI with a Buy rating and announced a price target of $4. SoFi Technologies, Inc. ...